出版：MarketsandMarkets（マーケッツアンドマーケッツ） 出版年月：2021年12月
ウイルス学標本収集市場: 製品（ウイルス輸送メディア、綿棒、採血キット、検体採取チューブ）、サンプルタイプ（血液、子宮頸部、鼻、鼻咽頭、喉、口腔）、地域別 – 2026年までの世界予測
Virology Specimen Collection Market by Product (Viral Transport Media, Swabs, Blood Collection Kits, Specimen Collection Tubes), Sample Type (Blood, Cervical, Nasal, Nasopharyngeal, Throat, Oral), Region-Global Forecast to 2026
| ページ数 | 78 |
| 図表数 | 42 |
| 種別 | 英文調査報告書 |
| 価格 |
The global virology specimen collectionmarket is projected to reach USD 5.4billion by 2026 from USD 5.6billion in 2021, at a CAGR of -0.6% during the forecast period. Market growth is driven by factors such as the growth in rising number of blood donations and rising prevalence of viral diseases and emergence of newer pathogens. On the other hand, high cost of technologies and collection kits and usage of flow sensitivity screening are the major factors hampering the growth of this market.
“The viral transport media segment accounted for the highest growth rate in thevirology specimen collectionmarket, by product, during the forecast period”
Thevirology specimen collectionmarket is segmented into test blood collection kits specimen collection tubes, swabs and viral transport media based on product. In 2020, the viral transport mediasegment accounted for the highest growth rate in the virology specimen collectionmarket. Rising number of blood donations is the major factor contributing to the growth of this segment.
“The blood samples segmentaccounted for the highest growth rate in the virology specimen collectionmarket, by sample type, during the forecast period”
The virology specimen collectionmarket is segmented into blood, nasopharyngeal, nasal, throat, cervical and oral based on sample type. In 2020, the blood sample segment accounted for the highest growth rate in the virology specimen collectionmarket.Rising prevalence of viral diseases and emergence of newer pathogens is themajor factor contributing to the growth of this segment.
“Asia Pacific: The fastest-growing regionin virology specimen collectionmarket”
The global virology specimen collectionmarket is segmented into North America, Europe, the Asia Pacific and Rest of the World. The Asia Pacific region is projected to register the highest CAGR during the forecast period.Factors such as the rising number of blood donationsare driving the growth of the virology specimen collectionmarket in this region.
The primary interviews conducted for this report can be categorized as follows:
•By Company Type: Tier 1 – 40%, Tier 2 – 30%,and Tier 3 -30%
•By Designation: C-level – 27%, D-level – 18%, and Others – 55%
•By Region: North America -51%, Europe – 21%, Asia Pacific – 18% and Rest of the World – 10%
Lists of Companies Profiled in the Report:
•Becton, Dickinson and Company (US)
•Quidel Corporation (US)
•Thermo Fisher Scientific, Inc. (US)
•Trinity Biotech (Ireland)
•Titan Biotech, Ltd. (India)
•Diasorin SA (Italy)
•Vircell S.L. (Spain)
•Copan Italia S.p.A. (Italy)
•Puritan Medical Products, Co. (Guilford, ME)
•Hardy Diagnostics (US).
Research Coverage:
This report provides a detailed picture of the global virology specimen collectionmarket. It aims at estimating the size and future growth potential of the market across different segments, such as product,sample type and region. The report also includes an in-depth competitive analysis ofthe key market players, along with their company profiles, recent developments, and key market strategies.
Key Benefits of Buying the Report:
The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall virology specimen collectionmarket and its subsegments.It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market’s pulse and provide them with information on the key market drivers, restraints, opportunities, and challenges.
目次
1INTRODUCTION13
1.1OBJECTIVES OF THE STUDY13
1.2MARKET DEFINITION13
1.2.1INCLUSIONS & EXCLUSIONS OF THE STUDY13
1.2.2MARKETS COVERED14
FIGURE 1VIROLOGY SPECIMEN COLLECTION MARKET SEGMENTATION14
1.2.3YEARS CONSIDERED FOR THE STUDY14
1.3CURRENCY15
1.4LIMITATIONS15
1.5STAKEHOLDERS15
2RESEARCH METHODOLOGY16
2.1RESEARCH DATA16
2.2RESEARCH APPROACH16
FIGURE 2VIROLOGY SPECIMEN COLLECTION MARKET: RESEARCH DESIGN16
2.2.1SECONDARY DATA17
2.2.1.1Key data from secondary sources17
2.2.2PRIMARY DATA18
2.2.2.1Key data from primary sources18
2.2.2.2Key industry insights19
FIGURE 3BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE,
DESIGNATION, AND REGION19
2.3MARKET SIZE ESTIMATION20
2.3.1BOTTOM-UP APPROACH20
FIGURE 4CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS20
2.3.2TOP-DOWN APPROACH20
FIGURE 5VIROLOGY SPECIMEN COLLECTION MARKET: TOP-DOWN APPROACH21
2.4ASSUMPTIONS FOR THE STUDY21
2.5GROWTH RATE ASSUMPTIONS22
2.6LIMITATIONS22
2.7RISK ASSESSMENT22
2.8COVID-19 HEALTH ASSESSMENT22
2.9COVID-19 ECONOMIC ASSESSMENT23
2.10ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO23
FIGURE 6CRITERIA IMPACTING THE GLOBAL ECONOMY23
FIGURE 7RECOVERY SCENARIO OF THE GLOBAL ECONOMY24
2.11ASSESSMENT OF THE IMPACT OF COVID-19 ON THE VIROLOGY SPECIMEN
COLLECTION MARKET25
3MARKET OVERVIEW26
3.1INTRODUCTION26
3.2MARKET DYNAMICS26
FIGURE 8VIROLOGY SPECIMEN COLLECTION MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES26
3.2.1DRIVERS27
3.2.1.1Rising prevalence of viral diseases and emergence of
newer pathogens27
3.2.1.2Rising number of blood donations27
3.2.2RESTRAINTS28
3.2.2.1Need for alternative technologies28
3.2.3OPPORTUNITIES28
3.2.3.1Technological advancements28
3.2.3.2Lucrative opportunities in emerging economies29
3.2.4CHALLENGES29
3.2.4.1High cost of technologies and collection kits29
3.2.4.2Usage of low-sensitivity screening30
3.3IMPACT OF COVID-19 ON THE VIROLOGY SPECIMEN COLLECTION MARKET30
3.4PESSIMISTIC, OPTIMISTIC, AND REALISTIC SCENARIOS31
3.4.1VIROLOGY SPECIMEN COLLECTION MARKET31
FIGURE 9PESSIMISTIC SCENARIO31
FIGURE 10OPTIMISTIC SCENARIO32
FIGURE 11REALISTIC SCENARIO32
3.5PRICING ANALYSIS33
TABLE 1PRICE OF VIROLOGY SPECIMEN COLLECTION PRODUCTS (2021)33
3.6PATENT ANALYSIS33
3.6.1PATENT ANALYSIS OF VIRAL TRANSPORT MEDIA33
3.6.2PATENT ANALYSIS OF BLOOD COLLECTION KITS34
3.7TRADE ANALYSIS34
3.7.1TRADE ANALYSIS FOR DIAGNOSTIC REAGENTS34
TABLE 2IMPORT DATA FOR PREPARED CULTURE MEDIA FOR THE DEVELOPMENT OR MAINTENANCE OF MICRO-ORGANISMS INCL. VIRUSES AND THE LIKE OR OF PLANT, HUMAN OR ANIMAL CELLS, BY COUNTRY, 2016–2020 (USD MILLION)34
TABLE 3EXPORT DATA FOR PREPARED CULTURE MEDIA FOR THE DEVELOPMENT OR MAINTENANCE OF MICRO-ORGANISMS INCL. VIRUSES AND THE LIKE OR OF PLANT, HUMAN OR ANIMAL CELLS, BY COUNTRY, 2016–2020 (USD MILLION)35
3.8VALUE CHAIN ANALYSIS35
FIGURE 12MAJOR VALUE IS ADDED DURING THE MANUFACTURING & ASSEMBLY PHASE35
3.9SUPPLY CHAIN ANALYSIS36
FIGURE 13VIROLOGY SPECIMEN COLLECTION MARKET: SUPPLY CHAIN ANALYSIS37
3.10ECOSYSTEM ANALYSIS OF THE VIROLOGY SPECIMEN COLLECTION MARKET37
FIGURE 14VIROLOGY SPECIMEN COLLECTION MARKET: ECOSYSTEM ANALYSIS37
3.10.1ROLE IN ECOSYSTEM37
3.11PORTER’S FIVE FORCES ANALYSIS38
TABLE 4VIROLOGY SPECIMEN COLLECTION MARKET: PORTER’S FIVE
FORCES ANALYSIS38
3.11.1THREAT OF NEW ENTRANTS38
3.11.2THREAT OF SUBSTITUTES38
3.11.3BARGAINING POWER OF BUYERS38
3.11.4BARGAINING POWER OF SUPPLIERS38
3.11.5DEGREE OF COMPETITION39
3.12REGULATORY LANDSCAPE39
3.12.1NORTH AMERICA39
3.12.1.1US39
3.12.1.2Canada39
3.12.2EUROPE39
3.12.3ASIA PACIFIC40
3.12.3.1Japan40
3.12.3.2India40
3.12.4LATIN AMERICA40
3.12.4.1Brazil40
3.12.4.2Mexico40
3.12.5MIDDLE EAST41
3.13CASE STUDY ANALYSIS41
3.13.1CASE STUDY 141
3.14TECHNOLOGY ANALYSIS41
3.15TRENDS/DISRUPTIONS IMPACTING THE BUSINESS OF CUSTOMERS43
3.15.1REVENUE SOURCES ARE SHIFTING TOWARD MORE TECHNOLOGY-BASED SOLUTIONS DUE TO THE COVID-19 PANDEMIC43
3.15.2REVENUE SHIFT FOR THE VIROLOGY SPECIMEN COLLECTION MARKET43
4VIROLOGY SPECIMEN COLLECTION MARKET, BY PRODUCT TYPE44
4.1INTRODUCTION45
TABLE 5VIROLOGY SPECIMEN COLLECTION MARKET, BY PRODUCT TYPE,
2019–2026 (USD MILLION)45
4.2VIRAL TRANSPORT MEDIA45
4.2.1REPEAT PURCHASE OF VIRAL TRANSPORT MEDIA TO DRIVE MARKET
GROWTH IN THE COMING YEARS45
TABLE 6VIROLOGY SPECIMEN COLLECTION MARKET FOR VIRAL TRANSPORT
MEDIA, BY REGION, 2019–2026 (USD MILLION)46
4.3SPECIMEN COLLECTION TUBES46
4.3.1SURGE IN PATIENT POPULATION TO DRIVE SEGMENT GROWTH46
TABLE 7VIROLOGY SPECIMEN COLLECTION MARKET FOR SPECIMEN COLLECTION TUBES, BY REGION, 2019–2026 (USD MILLION)46
4.4SWABS47
4.4.1INCREASING INCIDENCE OF VIRAL DISEASES TO PROPEL MARKET GROWTH47
TABLE 8VIROLOGY SPECIMEN COLLECTION MARKET FOR SWABS, BY REGION,
2019–2026 (USD MILLION)47
4.5BLOOD COLLECTION KITS48
4.5.1GROWING PRESSURE ON CLINICAL LABORATORIES TO DRIVE THE
MARKET GROWTH48
TABLE 9VIROLOGY SPECIMEN COLLECTION MARKET FOR BLOOD COLLECTION
KITS, BY REGION, 2019–2026 (USD MILLION)48
5VIROLOGY SPECIMEN COLLECTION MARKET, BY SAMPLE49
5.1INTRODUCTION50
TABLE 10VIROLOGY SPECIMEN COLLECTION MARKET, BY SAMPLE,
2019–2026 (USD MILLION)50
5.2BLOOD SAMPLES50
5.2.1RISING NUMBER OF LEUKEMIA AND LYMPHOMA CASES WILL SUPPORT
THE MARKET GROWTH50
TABLE 11VIROLOGY SPECIMEN COLLECTION MARKET FOR BLOOD SAMPLES,
BY REGION, 2019–2026 (USD MILLION)51
5.3CERVICAL SAMPLES51
5.3.1INCREASING INCIDENCE OF HPV WILL DRIVE THE GROWTH OF THIS SEGMENT51
TABLE 12VIROLOGY SPECIMEN COLLECTION MARKET FOR CERVICAL SAMPLES,
BY REGION, 2019–2026 (USD MILLION)52
5.4NASAL SAMPLES52
5.4.1RISING PREVALENCE OF RESPIRATORY DISORDERS TO SUPPORT THE MARKET GROWTH52
TABLE 13VIROLOGY SPECIMEN COLLECTION MARKET FOR NASAL SAMPLES,
BY REGION, 2019–2026 (USD MILLION)52
5.5NASOPHARYNGEAL SAMPLES53
5.5.1INCREASE IN NUMBER OF RT-PCR TESTS WILL DRIVE THE GROWTH
OF THIS SEGMENT53
TABLE 14VIROLOGY SPECIMEN COLLECTION MARKET FOR NASOPHARYNGEAL SAMPLES, BY REGION, 2019–2026 (USD MILLION)53
5.6THROAT SAMPLES53
5.6.1INCREASING PREVALENCE OF VIRAL DISEASES TO DRIVE THE
SEGMENT GROWTH53
TABLE 15VIROLOGY SPECIMEN COLLECTION MARKET FOR THROAT SAMPLES,
BY REGION, 2019–2026 (USD MILLION)54
5.7ORAL SAMPLES54
5.7.1QUICK DIAGNOSTIC RESULTS THROUGH ORAL SWABS TO DRIVE
THE GROWTH OF THIS MARKET54
TABLE 16VIROLOGY SPECIMEN COLLECTION MARKET FOR ORAL SAMPLES,
BY REGION, 2019–2026 (USD MILLION)54
5.8OTHER SAMPLES55
TABLE 17VIROLOGY SPECIMEN COLLECTION MARKET FOR OTHER SAMPLES,
BY REGION, 2019–2026 (USD MILLION)55
6VIROLOGY SPECIMEN COLLECTION MARKET, BY REGION56
6.1INTRODUCTION57
TABLE 18VIROLOGY SPECIMEN COLLECTION MARKET, BY REGION,
2019–2026 (USD MILLION)57
6.2NORTH AMERICA57
6.2.1RISING PREVALENCE OF HIV IN THE REGION WILL SUPPORT THE MARKET GROWTH57
FIGURE 15NORTH AMERICA: VIROLOGY SPECIMEN COLLECTION MARKET SNAPSHOT58
TABLE 19NORTH AMERICA: VIROLOGY SPECIMEN COLLECTION MARKET, BY PRODUCT TYPE, 2019–2026 (USD MILLION)59
TABLE 20NORTH AMERICA: VIROLOGY SPECIMEN COLLECTION MARKET, BY SAMPLE, 2019–2026 (USD MILLION)59
6.3EUROPE59
6.3.1RISING INCIDENCE OF HUMAN PAPILLOMAVIRUS TO SUPPORT GROWTH59
TABLE 21EUROPE: VIROLOGY SPECIMEN COLLECTION MARKET, BY PRODUCT TYPE, 2019–2026 (USD MILLION)60
TABLE 22EUROPE: VIROLOGY SPECIMEN COLLECTION MARKET, BY SAMPLE,
2019–2026 (USD MILLION)60
6.4ASIA PACIFIC61
6.4.1APAC MARKET IS MAINLY DRIVEN BY LARGE-SCALE COVID TESTING ACTIVITY61
FIGURE 16ASIA PACIFIC: VIROLOGY SPECIMEN COLLECTION MARKET SNAPSHOT62
TABLE 23ASIA PACIFIC: VIROLOGY SPECIMEN COLLECTION MARKET, BY PRODUCT TYPE, 2019–2026 (USD MILLION)62
TABLE 24ASIA PACIFIC: VIROLOGY SPECIMEN COLLECTION MARKET, BY SAMPLE, 2019–2026 (USD MILLION)63
6.5REST OF THE WORLD63
TABLE 25REST OF THE WORLD: VIROLOGY SPECIMEN COLLECTION MARKET,
BY PRODUCT TYPE, 2019–2026 (USD MILLION)64
TABLE 26REST OF THE WORLD: VIROLOGY SPECIMEN COLLECTION MARKET,
BY SAMPLE, 2019–2026 (USD MILLION)64
7COMPANY PROFILES65
7.1KEY PLAYERS65
7.1.1BECTON, DICKINSON AND COMPANY65
7.1.2QUIDEL CORPORATION66
7.1.3THERMO FISHER SCIENTIFIC, INC.67
7.1.4TRINITY BIOTECH68
7.1.5TITAN BIOTECH LTD.69
7.1.6DIASORIN SA69
7.1.7VIRCELL S.L.70
7.1.8COPAN ITALIA S.P.A70
7.1.9PURITAN MEDICAL PRODUCTS CO.71
7.1.10HARDY DIAGNOSTICS72
8APPENDIX73
8.1INSIGHTS FROM INDUSTRY EXPERTS73
8.2DISCUSSION GUIDE74
8.3KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL76
8.4AVAILABLE CUSTOMIZATIONS78
8.5AUTHOR DETAILS79